참고문헌
- Ahmed NS, Shafik NM, Elraheem OA, et al (2015). Association of paraoxonase-1(Q192R and L55M) gene polymorphisms and activity with colorectal cancer and effect of surgical intervention. Asian Pac J Cancer Prev, 16, 803-9. https://doi.org/10.7314/APJCP.2015.16.2.803
- Akcay MN, Polat MF, Yilmaz I, et al (2003a). Serum paraoxonase levels in pancreatic cancer. Hepatogastroenterology, 50, ccxxv-ccxxvii.
- Akcay MN, Yilmaz I, Polat MF, et al (2003b). Serum paraoxonase levels in gastric cancer. Hepatogastroenterology, 50, cclxxiii-cclxxv.
- Akkiz H, Kuran S, Akgollu E, et al (2013). Effect of PON1 gene polymorphisms in Turkish patients with hepatocellular carcinoma. Meta Gene, 1, 93-101. https://doi.org/10.1016/j.mgene.2013.09.007
- Aksoy-Sagirli P, Cakmakoglu B, Isbir T, et al (2011). Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population. Anticancer Res, 31, 2225-9.
- Ames BN (1983). Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science, 221, 1256-64. https://doi.org/10.1126/science.6351251
- Antognelli C, Del Buono C, Ludovini V, et al (2009). CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study. BMC Cancer, 9, 115. https://doi.org/10.1186/1471-2407-9-115
- Antognelli C, Mearini L, Talesa VN, et al (2005). Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer. Prostate, 63, 240-51. https://doi.org/10.1002/pros.20184
- Antognelli C, Mezzasoma L, Mearini E, et al (2013). Glyoxalase 1-419C>A variant is associated with oxidative stress: implications in prostate cancer progression. PLoS One, 8, 74014. https://doi.org/10.1371/journal.pone.0074014
- Arpaci A, Gormus U, Dalan B, et al (2009). Investigation of PON1 192 and PON1 55 polymorphisms in ovarian cancer patients in Turkish population. In Vivo, 23, 421-4.
- Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
- Bredberg A (2011). Cancer: more of polygenic disease and less of multiple mutations? A quantitative viewpoint. Cancer, 117, 440-5. https://doi.org/10.1002/cncr.25440
- Cejas P, Casado E, Belda-Iniesta C, et al (2004). Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control, 15, 707-19. https://doi.org/10.1023/B:CACO.0000036189.61607.52
- Conesa-Zamora P, Ruiz-Cosano J, Torres-Moreno D, et al (2013). Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study. BMC Cancer, 13, 228. https://doi.org/10.1186/1471-2407-13-228
- Davies HG, Richter RJ, Keifer M, et al (1996). The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet, 14, 334-6. https://doi.org/10.1038/ng1196-334
- de Aguiar Goncalves BA, Vasconcelos GM, Thuler LC, et al (2012). NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution. Cancer Causes Control, 23, 1811-9. https://doi.org/10.1007/s10552-012-0060-5
- Delimaris I, Faviou E, Antonakos G, et al (2007). Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin Biochem, 40, 1129-34. https://doi.org/10.1016/j.clinbiochem.2007.06.007
- DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
- Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
- Elkiran ET, Mar N, Aygen B, et al (2007). Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer, 7, 48. https://doi.org/10.1186/1471-2407-7-48
- Ellidag HY, Aydin O, Eren E, et al (2014). Decreased HDLdependent paraoxonase and arylesterase enzyme activity may indicate a worse prognosis in multiple myeloma. Asian Pac J Cancer Prev, 15, 9847-51. https://doi.org/10.7314/APJCP.2014.15.22.9847
- Eom SY, Yim DH, Lee CH, et al (2015). Interactions between paraoxonase 1 genetic polymorphisms and smoking and their effects on oxidative stress and lung cancer risk in a Korean Population. PLoS One, 10, 119100.
- Ergen A, Kilicoglu O, Ozger H, et al (2011). Paraoxonase 1 192 and 55 polymorphisms in osteosarcoma. Mol Biol Rep, 38, 4181-4. https://doi.org/10.1007/s11033-010-0538-8
- Gallicchio L, McSorley MA, Newschaffer CJ, et al (2007). Body mass, polymorphisms in obesity-related genes, and the risk of developing breast cancer among women with benign breast disease. Cancer Detect Prev, 31, 95-101. https://doi.org/10.1016/j.cdp.2007.02.004
- Humbert R, Adler DA, Disteche CM, et al (1993). The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet, 3, 73-6. https://doi.org/10.1038/ng0193-73
- Hussein YM, Gharib AF, Etewa RL, et al (2011). Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance. Mol Cell Biochem, 351, 117-23. https://doi.org/10.1007/s11010-011-0718-4
- Kafadar AM, Ergen A, Zeybek U, et al (2006). Paraoxonase 192 gene polymorphism and serum paraoxonase activity in high grade gliomas and meningiomas. Cell Biochem Funct, 24, 455-60. https://doi.org/10.1002/cbf.1284
- Karaman E, Uzun H, Papila I, et al (2010). Serum paraoxonase activity and oxidative DNA damage in patients with laryngeal squamous cell carcinoma. J Craniofac Surg, 21, 1745-9. https://doi.org/10.1097/SCS.0b013e3181f4040a
- Kerridge I, Lincz L, Scorgie F, et al (2002). Association between xenobiotic gene polymorphisms and non-Hodgkin’s lymphoma risk. Br J Haematol, 118, 477-81. https://doi.org/10.1046/j.1365-2141.2002.03606.x
- Kokouva M, Koureas M, Dardiotis E, et al (2013). Relationship between the paraoxonase 1 (PON1) M55L and Q192R polymorphisms and lymphohaematopoietic cancers in a Greek agricultural population. Toxicology, 307, 12-6. https://doi.org/10.1016/j.tox.2012.07.003
- Lee CH, Lee KY, Choe KH, et al (2005). Effects of oxidative DNA damage induced by polycyclic aromatic hydrocarbons and genetic polymorphism of the paraoxonase-1 (PON1) gene on lung cancer. J Prev Med Public Health, 38, 345-50.
- Li WF, Costa LG, Richter RJ, et al (2000). Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics, 10, 767-79. https://doi.org/10.1097/00008571-200012000-00002
- Lincz LF, Kerridge I, Scorgie FE, et al (2004). Xenobiotic gene polymorphisms and susceptibility to multiple myeloma. Haematologica, 89, 628-9.
- Lurie G, Wilkens LR, Thompson PJ, et al (2008). Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma. Cancer Epidemiol Biomarkers Prev, 17, 2070-7. https://doi.org/10.1158/1055-9965.EPI-08-0145
- Mackness B, Mackness MI, Arrol S, et al (1997). Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br J Pharmacol, 122, 265-8. https://doi.org/10.1038/sj.bjp.0701390
- Martinez C, Molina JA, Alonso-Navarro H, et al (2010). Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma. BMC Neurol, 10, 71. https://doi.org/10.1186/1471-2377-10-71
- Naidu R, Har YC, Taib NA (2010). Genetic polymorphisms of paraoxonase 1 (PON1) gene: association between L55M or Q192R with breast cancer risk and clinico-pathological parameters. Pathol Oncol Res, [Epub ahead of print].
- Ozturk O, Kagnici OF, Ozturk T, et al (2009). 192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer. Anticancer Res, 29, 4041-6.
- Pharoah PD, Dunning AM, Ponder BA, et al (2004). Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer, 4, 850-60. https://doi.org/10.1038/nrc1476
- Rajaraman P, Hutchinson A, Rothman N, et al (2008). Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol, 10, 709-15. https://doi.org/10.1215/15228517-2008-037
- Searles Nielsen S, Mueller BA, De Roos AJ, et al (2005). Risk of brain tumors in children and susceptibility to organophosphorus insecticides: the potential role of paraoxonase (PON1). Environ Health Perspect, 113, 909-13. https://doi.org/10.1289/ehp.7680
- Stevens VL, Rodriguez C, Talbot JT, et al (2008). Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II nutrition cohort. Prostate, 68, 1336-40. https://doi.org/10.1002/pros.20796
- Sun Y (1990). Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med, 8, 583-99. https://doi.org/10.1016/0891-5849(90)90156-D
- Tobias A, Campbell MJ (1999). Modelling influenza epidemics in the relation between black smoke and total mortality. A sensitivity analysis. J Epidemiol Community Health, 53, 583-4. https://doi.org/10.1136/jech.53.9.583
- Torre LA, Bray F, Siegel RL, et al (2015). Global cancer statistics, 2012. CA Cancer J Clin, 65, 87-108. https://doi.org/10.3322/caac.21262
- Uyar OA, Kara M, Erol D, et al (2011). Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer. Genet Mol Res, 10, 133-9. https://doi.org/10.4238/vol10-1gmr927
- Van Der Logt EM, Janssen CH, Van Hooijdonk Z, et al (2005). No association between genetic polymorphisms in NAD(P) H oxidase p22phox and paraoxonase 1 and colorectal cancer risk. Anticancer Res, 25, 1465-70.
- Vasconcelos GM, Goncalves BA, Montalvao-de-Azevedo R, et al (2014). PON1 Q192R polymorphism (rs662) is associated with childhood embryonal tumors. Mol Biol Rep, 41, 6111-5. https://doi.org/10.1007/s11033-014-3489-7
- Vecka M, Jachymova M, Vavrova L, et al (2012). Paraoxonase-1 (PON1) status in pancreatic cancer: relation to clinical parameters. Folia Biol (Praha), 58, 231-7.
- Wang H, Li L, Ding L, et al (2012). Association of genetic polymorphisms in the paraoxonase 1 gene with the risk and prognosis of non-small cell lung cancer in Chinese Han population. J Investig Med, 60, 592-7. https://doi.org/10.2310/JIM.0b013e318245d557
- Zamora-Ros R, Rothwell JA, Scalbert A, et al (2013). Dietary intakes and food sources of phenolic acids in the European Prospective Investigation into cancer and nutrition (EPIC) study. Br J Nutr, 110, 1500-11. https://doi.org/10.1017/S0007114513000688
- Zhao P, Zhao L, Zou P, et al (2012). Genetic oxidative stress variants and glioma risk in a Chinese population: a hospitalbased case-control study. BMC Cancer, 12, 617. https://doi.org/10.1186/1471-2407-12-617
피인용 문헌
- Serum paraoxonase 1 activity and protein N-homocysteinylation in primary human endometrial cancer vol.40, pp.9, 2018, https://doi.org/10.1177/1010428318797869